AWM
URGN icon

Activest Wealth Management’s UroGen Pharma URGN Stock Holding History

Activest Wealth Management’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8K Hold
1,001
– – 0.01% 324
2026
Q1 		$18K Hold
1,001
– – ﹤0.01% 551
2025
Q4 		$23.4K Hold
1,001
– – ﹤0.01% 470
2025
Q3 		$20K Hold
1,001
– – ﹤0.01% 382
2025
Q2 		$13.7K Hold
1,001
– – ﹤0.01% 378
2025
Q1 		$11.1K Hold
1,001
– – ﹤0.01% 381
2024
Q4 		$10.7K Hold
1,001
– – ﹤0.01% 310
2024
Q3 		$12.7K Hold
1,001
– – ﹤0.01% 295
2024
Q2 		$16.8K Buy
+1,001
New +$14.2K 0.01% 251

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Activest Wealth Management's URGN Position: Q2 2026 in Review

Activest Wealth Management held its UroGen Pharma (URGN) position steady in Q2 2026 at 1,001 shares worth $36.8K. The position accounts for 0.01% of the portfolio, ranked #324.

Activest Wealth Management first reported a position in URGN in Q2 2024 and has held it in 9 quarters since. 190 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Activest Wealth Management held 1,001 shares of UroGen Pharma worth $36.8K as of Q2 2026.
  • Activest Wealth Management left its UroGen Pharma share count unchanged in Q2 2026.
  • UroGen Pharma made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #324 holding.
  • Activest Wealth Management first reported a position in UroGen Pharma in Q2 2024 and has held it in 9 quarters since.
  • 190 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.